The antiviral effect of jiadifenoic acids C against coxsackievirus B3.
10.1016/j.apsb.2014.06.008
- Author:
Miao GE
1
;
Huiqiang WANG
1
;
Guijie ZHANG
2
;
Shishan YU
2
;
Yuhuan LI
1
Author Information
1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
- Publication Type:Journal Article
- Keywords:
Antiviral activity;
CAR, coxsackievirus and adenovirus receptor;
CPE, cytopathic effect;
CVB3;
CVB3, coxsackievirus B type 3;
CVBs, coxsackie B viruses;
DAF, decay accelerating factor;
DCM, dilated cardiomyopathy;
IC50, 50% inhibitory concentration;
IRES, internal ribosomal entry site;
Jiadifenoic acids C;
MOI, multiplicity of infection;
NTR, non-translated region;
RBV, ribavirin;
RdRp, RNA-dependent RNA polymerase;
SI, selectivity index;
Vero, African green monkey kidney cells
- From:
Acta Pharmaceutica Sinica B
2014;4(4):277-283
- CountryChina
- Language:English
-
Abstract:
Coxsackievirus B type 3 (CVB3) is one of the major causative pathogens associated with viral meningitis and myocarditis, which are widespread in the human population and especially prevalent in neonates and children. These infections can result in dilated cardiomyopathy (DCM) and other severe clinical complications. There are no vaccines or drugs approved for the prevention or therapy of CVB3-induced diseases. During screening for anti-CVB3 candidates in our previous studies, we found that jiadifenoic acids C exhibited strong antiviral activities against CVB3 as well as other strains of Coxsackie B viruses (CVBs). The present studies were carried out to evaluate the antiviral activities of jiadifenoic acids C. Results showed that jiadifenoic acids C could reduce CVB3 RNA and proteins synthesis in a dose-dependent manner. Jiadifenoic acids C also had a similar antiviral effect on the pleconaril-resistant variant of CVB3. We further examined the impact of jiadifenoic acids C on the synthesis of viral structural and non-structural proteins, finding that jiadifenoic acids C could reduce VP1 and 3D protein production. A time-course study with Vero cells showed that jiadifenoic acids C displayed significant antiviral activities at 0-6 h after CVB3 inoculation, indicating that jiadifenoic acids C functioned at an early step of CVB3 replication. However, jiadifenoic acids C had no prophylactic effect against CVB3. Taken together, we show that jiadifenoic acids C exhibit strong antiviral activities against all strains of CVB, including the pleconaril-resistant variant. Our study could provide a significant lead for anti-CVB3 drug development.
